Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $823.55 billion, total revenue of $172.71 billion and a weighted average PE ratio of 45.53.
Market Cap
823.55B
Revenue
172.71B
Profits
18.09B
PE Ratio
45.53
Profit Margin
10.47%
Dividend Yield
0.21%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 226.88B | 0.62% | 1,271,147 | 46.34B |
| 2 | DHR | Danaher Corporation | 142.88B | 1.55% | 3,657,137 | 25.11B |
| 3 | NTRA | Natera, Inc. | 49.27B | 3.91% | 1,043,162 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 43.73B | 1.49% | 1,279,777 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 41.39B | -0.09% | 1,646,764 | 7.37B |
| 6 | WAT | Waters Corporation | 40.28B | 0.41% | 728,761 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 40.14B | 0.96% | 447,363 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 31.44B | 0.85% | 1,982,097 | 4.49B |
| 9 | DGX | Quest Diagnostics Incorporated | 26.26B | 1.22% | 974,845 | 11.56B |
| 10 | MTD | Mettler-Toledo International Inc. | 25.76B | -0.60% | 228,283 | 4.13B |
| 11 | LH | Labcorp Holdings Inc. | 25.57B | 1.21% | 707,835 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.52B | 6.65% | 1,488,157 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.62B | 1.34% | 206,313 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.34B | 3.36% | 1,895,183 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.04B | -1.85% | 1,594,816 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.03B | -0.22% | 1,325,061 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.66B | -1.46% | 2,036,577 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 5.94B | - | 1,177,374 | 2.27B |
| 19 | SHC | Sotera Health Company | 5.29B | 0.82% | 1,573,519 | 1.22B |
| 20 | BLLN | BillionToOne, Inc. | 4.76B | 2.08% | 420,203 | 397.41M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 2.40% | 1,730,340 | 308.08M |
| 22 | GRAL | GRAIL, Inc. | 3.37B | -0.92% | 1,121,483 | 165.26M |
| 23 | VCYT | Veracyte, Inc. | 3.31B | 0.83% | 1,032,465 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 2.71B | 4.20% | 795,524 | 458.09M |
| 25 | WGS | GeneDx Holdings Corp. | 2.68B | 5.24% | 532,959 | 454.43M |
| 26 | NEO | NeoGenomics, Inc. | 2.37B | 6.29% | 1,503,398 | 766.30M |
| 27 | PSNL | Personalis, Inc. | 1.74B | 0.49% | 1,690,001 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.61B | 4.11% | 755,692 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.16B | -0.64% | 2,147,099 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.02B | 3.43% | 165,373 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 568.19M | 0.98% | 336,328 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 362.51M | 10.82% | 2,599,404 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 289.10M | 1.59% | 54,986 | 102.94M |
| 34 | XGN | Exagen Inc. | 178.06M | 4.55% | 192,591 | 71.12M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 131.55M | -4.29% | 526,826 | 1.67M |
| 36 | BNR | Burning Rock Biotech Limited | 122.34M | -5.54% | 238,833 | 73.70M |
| 37 | QUCY | Quantum Cyber N.V. | 110.97M | -1.49% | 302,409 | 537.08K |
| 38 | MDXH | MDxHealth SA | 67.48M | 0.37% | 85,604 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 48.75M | -0.33% | 62,640 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 12.85M | -5.01% | 23,980 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.80M | 4.45% | 25,547 | - |
| 42 | XWEL | XWELL, Inc. | 7.99M | -3.61% | 32,679 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.28M | -0.25% | 366,281 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.70M | - | 176,048 | 466.30K |